Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for steroid-induced elevated intraocular pressure
2006-003356-38Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of anecortave in ocular hypertension (4 arms), sponsored by Alcon Inc. Primary endpoint: Mean change in intraocular pressure from baseline to Week 4. Started Sep 2006; status: completed.
02
Drugs
anecortave
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on 2006-003356-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003356-38.